13 found
Order:
  1.  15
    Ethics of Decoded Neurofeedback in Clinical Research, Treatment, and Moral Enhancement.Eisuke Nakazawa, Keiichiro Yamamoto, Koji Tachibana, Soichiro Toda, Yoshiyuki Takimoto & Akira Akabayashi - 2016 - American Journal of Bioethics Neuroscience 7 (2):110-117.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  2.  16
    Endangerment of the iPSC Stock Project in Japan: On the Ethics of Public Funding Policies.Akira Akabayashi, Eisuke Nakazawa & Nancy S. Jecker - 2018 - Journal of Medical Ethics 44 (10):700-702.
    We examined the ethical justification for a national policy governing public funding for the induced pluripotent stem cell stock project in Japan and argue that the initiation of the iPSC stock project in 2012, when no clinical trial using iPSC-derived products had yet succeeded, was premature and unethical. Our analysis considers a generally accepted justice criterion and shows it fails to justify public funding of the iPSC stock project. We also raise concerns related to the massive amounts of public funding (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  3.  12
    A Global Dialogue on Withholding and Withdrawal of Medical Care: An East Asian Perspective.Akira Akabayashi, Reina Ozeki-Hayashi, Keiichiro Yamamoto & Eisuke Nakazawa - 2019 - American Journal of Bioethics 19 (3):50-52.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  8
    Why Can’T Japanese People Decide?—Withdrawal of Ventilatory Support in End-of-Life Scenarios and Their Indecisiveness.Eisuke Nakazawa, Keiichiro Yamamoto, Reina Ozeki-Hayashi & Akira Akabayashi - 2019 - Asian Bioethics Review 11 (4):343-347.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  11
    Fairness and Desert: A Critique of the Random Selection Criterion in Clinical Trials.Eisuke Nakazawa, Keiichiro Yamamoto & Akira Akabayashi - 2018 - American Journal of Bioethics 18 (4):81-82.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  6.  2
    Implementation of Japan’s First Clinical Research Regulatory Law: Background, Overview, and Challenges.Akira Akabayashi, Eisuke Nakazawa & Aru Akabayashi - 2019 - HEC Forum 31 (4):283-294.
    In April 2018, Japan’s first law regulating clinical research went into effect. The law aimed to strengthen regulations on research integrity and conflicts of interest, which had been limited under existing administrative guidelines; the law also provided stipulations for legal penalties. The scope of the new regulations, however, is limited entirely to studies that evaluate unapproved drugs or the off-label use of approved drugs, and those that receive funding from companies. On the other hand, the law’s application brings numerous complications, (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  7. Solitary Death and New Lifestyles During and After COVID-19: Wearable Devices and Public Health Ethics.Akira Akabayashi, Alex John London, Keiichiro Yamamoto & Eisuke Nakazawa - 2021 - BMC Medical Ethics 22 (1):1-10.
    BackgroundSolitary death has recently become recognized as a social issue in Japan. The social isolation of older people leads to death without dignity. With the outbreak of COVID-19, efforts to eliminate solitary death need to be adjusted in line with changes in lifestyle and accompanying changes in social structure. Health monitoring services that utilize wearable devices may contribute to this end. Our goals are to outline how wearable devices might be used to detect emergency situations involving solitary older people and (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  8.  7
    What Are Considered ‘Good Facts’?Akira Akabayashi, Eisuke Nakazawa & Nancy S. Jecker - 2019 - Journal of Medical Ethics 45 (7):473-475.
    In the January edition of the Journal of Medical Ethics, Fujita and Tabuchi responded that we misunderstood the ‘facts’ in our previous article. Our article’s method was twofold. First, it appealed to normative analysis and publicly accessible materials, and second, it targeted a policy-making approach to public funding. We specifically did not focus on the Center for iPS Cell Research and Application or induced pluripotent stem stock projects. The Authors raised five criticisms, including transparency of our interpretation of public funding (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  9.  4
    Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps.Hiroyasu Ino, Eisuke Nakazawa & Akira Akabayashi - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (1):51-58.
    While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing. However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When drug repurposing is employed in emergency situations, the fairness of resource distribution becomes an issue that requires careful ethical consideration.This paper examines the drug repurposing in emergency situations focusing on the fairness using Japanese cases. Ethical issues under these circumstances addressed (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  13
    Regulations on Genome Editing of Human Embryos in Japan: Our Moral Moratorium.Eisuke Nakazawa, Keiichiro Yamamoto, Aru Akabayashi & Akira Akabayashi - 2018 - Cambridge Quarterly of Healthcare Ethics 27 (3):360-365.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  11.  11
    The Social Framework Surrounding the Development of Regenerative Medicine in Japan.Eisuke Nakazawa, Yoshiyuki Takimoto & Akira Akabayashi - 2016 - Cambridge Quarterly of Healthcare Ethics 25 (3):466-471.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  12.  5
    Will You Give My Kidney Back? Organ Restitution in Living-Related Kidney Transplantation: Ethical Analyses.Eisuke Nakazawa, Keiichiro Yamamoto, Aru Akabayashi, Margie H. Shaw, Richard A. Demme & Akira Akabayashi - 2020 - Journal of Medical Ethics 46 (2):144-150.
    In this article, we perform a thought experiment about living donor kidney transplantation. If a living kidney donor becomes in need of renal replacement treatment due to dysfunction of the remaining kidney after donation, can the donor ask the recipient to give back the kidney that had been donated? We call this problem organ restitution and discussed it from the ethical viewpoint. Living organ transplantation is a kind of ‘designated donation’ and subsequently has a contract-like character. First, assuming a case (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  13.  21
    Ordinary Citizens? Expectations for Regenerative Medicine and Induced Pluripotent Stem Cells Researches in Japan.Yoshiyuki Takimoto, Eisuke Nakazawa, Atsushi Tsuchiya & Akabayashi Akira - 2017 - Journal of Clinical Research and Bioethics 8 (5).
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark